Clinical Trial Update: Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing sarcosine for symptom relief, quality of life, oxidative stress, and glutamatergic measures in schizophrenia; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: Medical University of Lodz | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED